| Net Cash Provided by (Used in) Operating Activities |
$2,753,000 |
USD |
35% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$638,000 |
USD |
-60% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$375,000 |
USD |
93% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
300,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
1,856,815 |
shares |
-73% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$2,490,000 |
USD |
70% |
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$86,000 |
USD |
4.9% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$46,928,000 |
USD |
12% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$46,948,000 |
USD |
12% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$367,000 |
USD |
-40% |
Q3 2025 |
Q3 2025 |
| Depreciation |
$836,000 |
USD |
-18% |
Q3 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$289,000 |
USD |
-89% |
Q1 2025 |
Q1 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$622,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Property, Plant and Equipment, Gross |
$8,702,000 |
USD |
-54% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$194,000 |
USD |
-20% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.11 |
pure |
0% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$36,000 |
USD |
-57% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$40,380,000 |
USD |
11% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$500,000 |
USD |
0% |
Q4 2024 |
FY 2024 |
| Operating Lease, Payments |
$288,000 |
USD |
5.9% |
Q3 2025 |
Q3 2025 |
| Amortization of Intangible Assets |
$18,000 |
USD |
-60% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$20,000 |
USD |
-57% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$2,072,000 |
USD |
-26% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$551,000 |
USD |
83% |
Q1 2024 |
Q1 2024 |